Literature DB >> 23701892

Update on cystatin C: incorporation into clinical practice.

Michael G Shlipak1, Monica D Mattes, Carmen A Peralta.   

Abstract

Kidney function monitoring using creatinine-based glomerular filtration rate estimation is a routine part of clinical practice. Emerging evidence has shown that cystatin C may improve classification of glomerular filtration rate for defining chronic kidney disease in certain clinical populations and assist in understanding the complications of chronic kidney disease. In this review and update, we summarize the overall literature on cystatin C, critically evaluate recent high-impact studies, highlight the role of cystatin C in recent kidney disease guidelines, and suggest a practical approach for clinicians to incorporate cystatin C into practice. We conclude by addressing frequently asked questions related to implementing cystatin C use in a clinical setting.
Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cystatin C; chronic kidney disease; glomerular filtration rate (GFR) estimation

Mesh:

Substances:

Year:  2013        PMID: 23701892      PMCID: PMC3755100          DOI: 10.1053/j.ajkd.2013.03.027

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  50 in total

1.  Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy.

Authors:  B Stabuc; L Vrhovec; M Stabuc-Silih; T E Cizej
Journal:  Clin Chem       Date:  2000-02       Impact factor: 8.327

2.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

3.  Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.

Authors:  Mohammed A Sharawey; Eglal M Shawky; Lamia H Ali; Ahmed Ali Mohammed; Hatem A Hassan; Yasser M Fouad
Journal:  Hepatol Int       Date:  2011-03-12       Impact factor: 6.047

4.  Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Authors:  Carmen A Peralta; Michael G Shlipak; Suzanne Judd; Mary Cushman; William McClellan; Neil A Zakai; Monika M Safford; Xiao Zhang; Paul Muntner; David Warnock
Journal:  JAMA       Date:  2011-04-11       Impact factor: 56.272

5.  Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate.

Authors:  J Kyhse-Andersen; C Schmidt; G Nordin; B Andersson; P Nilsson-Ehle; V Lindström; A Grubb
Journal:  Clin Chem       Date:  1994-10       Impact factor: 8.327

6.  Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients.

Authors:  Edwin Bölke; Gisela Schieren; Stephan Gripp; Gerald Steinbach; Matthias Peiper; Klaus Orth; Christiane Matuschek; Maximilian Pelzer; Guido Lammering; Ruud Houben; Christina Antke; Lars Christian Rump; Rodrigo Mota; Peter Arne Gerber; Patrick Schuler; Thomas K Hoffmann; Ethelyn Rusnak; Derik Hermsen; Wilfried Budach
Journal:  Strahlenther Onkol       Date:  2011-02-24       Impact factor: 3.621

7.  Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.

Authors:  Andy Choi; Rebecca Scherzer; Peter Bacchetti; Phyllis C Tien; Michael S Saag; Cynthia L Gibert; Lynda A Szczech; Carl Grunfeld; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2010-08-14       Impact factor: 8.860

8.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

9.  KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.

Authors: 
Journal:  Am J Kidney Dis       Date:  2012-11       Impact factor: 8.860

10.  Cystatin C as a risk factor for outcomes in chronic kidney disease.

Authors:  Vandana Menon; Michael G Shlipak; Xuelei Wang; Josef Coresh; Tom Greene; Lesley Stevens; John W Kusek; Gerald J Beck; Allan J Collins; Andrew S Levey; Mark J Sarnak
Journal:  Ann Intern Med       Date:  2007-07-03       Impact factor: 25.391

View more
  60 in total

1.  Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated Individuals.

Authors:  Robert C Kalayjian; Kevin R Robertson; Jeffrey M Albert; Carl J Fichtenbaum; Todd T Brown; Babafemi O Taiwo
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

Review 2.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

3.  Creatinine Versus Cystatin C: Differing Estimates of Renal Function in Hospitalized Veterans Receiving Anticoagulants.

Authors:  Christina Hao Wang; Anna D Rubinsky; Tracy Minichiello; Michael G Shlipak; Erika Leemann Price
Journal:  J Gen Intern Med       Date:  2018-05-31       Impact factor: 5.128

4.  Cystatin C as a Predictor for Diabetes according to Glycosylated Hemoglobin Levels in Korean Patients.

Authors:  Eon Ju Jeon; Ji Hyun Lee
Journal:  Diabetes Metab J       Date:  2016-02       Impact factor: 5.376

5.  Sarcopenia Index Is a Simple Objective Screening Tool for Malnutrition in the Critically Ill.

Authors:  Erin F Barreto; Tejaswi Kanderi; Sara R DiCecco; Arnaldo Lopez-Ruiz; Janelle O Poyant; Kristin C Mara; Joy Heimgartner; Ognjen Gajic; Andrew D Rule; Erin M Nystrom; Kianoush B Kashani
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-12-18       Impact factor: 4.016

Review 6.  Surveillance and management of urologic complications after spinal cord injury.

Authors:  Evgeniy Kreydin; Blayne Welk; Doreen Chung; Quentin Clemens; Claire Yang; Teresa Danforth; Angelo Gousse; Stephanie Kielb; Stephen Kraus; Altaf Mangera; Sheilagh Reid; Nicole Szell; Francisco Cruz; Emmanuel Chartier-Kastler; David A Ginsberg
Journal:  World J Urol       Date:  2018-05-29       Impact factor: 4.226

7.  The performance of contemporary cystatin C-based GFR equations in predicting gentamicin clearance.

Authors:  Paul K L Chin; Janice S C Chew-Harris; Christopher M Florkowski; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

8.  The sarcopenia index: A novel measure of muscle mass in lung transplant candidates.

Authors:  Kianoush Kashani; Kumar Sarvottam; Naveen L Pereira; Erin F Barreto; Cassie C Kennedy
Journal:  Clin Transplant       Date:  2018-01-17       Impact factor: 2.863

Review 9.  Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries.

Authors:  Marcello Tonelli; James A Dickinson
Journal:  J Am Soc Nephrol       Date:  2020-08-24       Impact factor: 10.121

10.  Patterns of Cystatin C Uptake and Use Across and Within Hospitals.

Authors:  Hilary R Teaford; Andrew D Rule; Kristin C Mara; Kianoush B Kashani; John C Lieske; Diana J Schreier; Patrick M Wieruszewski; Erin F Barreto
Journal:  Mayo Clin Proc       Date:  2020-08       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.